This classification is supported by consistent findings that GDF-15 is associated with both disease-specific outcomes and all-cause mortality in the setting of various conditions, including cancer (21,22), stable coronary heart disease (14), atrial fibrillation (23,24), and acute coronary syndrome (10,25). Here, GDF15 is linked to cancer.